Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg
Christian R
CR
Department of OB/Gyn, University Breast Center Franconia, Univeristy Hospital Erlangen, Erlangen, Germany. christian.loehberg@uk-erlangen.de
Jud
Sebastian M
SM
Haeberle
Lothar
L
Heusinger
Katharina
K
Dilbat
Gerhard
G
Hein
Alexander
A
Rauh
Claudia
C
Dall
Peter
P
Rix
Nadine
N
Heinrich
Sabrina
S
Buchholz
Stefan
S
Lex
Benno
B
Reichler
Barbara
B
Adamietz
Boris
B
Schulz-Wendtland
Ruediger
R
Beckmann
Matthias W
MW
Fasching
Peter A
PA
D000367:Age Factors; D000368:Aged; D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control* / Q000523:psychology*; D018890:Chemoprevention / Q000379:methods; D004311:Double-Blind Method; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008327:Mammography; D008403:Mass Screening; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000523:psychology*; D012307:Risk Factors; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D014230:Triazoles / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole